PANCREAS 2025
Chairs: David Goldstein & Minoti Apte
Reprogramming the Immune Microenvironment in Pancreatic Cancer: New Metabolic Targets and Mechanistic Insights (130322)
9:00 AM
Assessing the Response of 3D Human Pancreatic Tumour Explants to Standard Chemotherapies (128151)
9:20 AM
Actin Cytoskeleton Dynamics in Tumor Cells Mediate Immune-Suppressive Microenvironment and Sensitize Pancreas Tumors to PD-1 Blockade Therapy (127017)
9:40 AM
Decoding the Tumour Microenvironment of Pancreatic Cancer Through Multi-Omics Approaches (126962)
9:50 AM
GOT1 Inhibition Reshapes the Extracellular Matrix of Pancreatic Cancer (126959)
10:00 AM
Targeting Circulating Hsp70 and Hsp90 to Mitigate Muscle Wasting in a Patient-Derived Xenograft Pancreatic Cancer Model in Mice (124852)
10:10 AM